Empagliflozin Amorphous

Generic Name: empagliflozin amorphous

Over-the-Counter (OTC)

Dosage form: POWDER. Active ingredients: EMPAGLIFLOZIN (1 kg/kg). Category: BULK INGREDIENT.

Overview

Dosage form: POWDER. Active ingredients: EMPAGLIFLOZIN (1 kg/kg). Category: BULK INGREDIENT.

Dosage

Available as powder.

Related Medications

Calendula Officinalis, Arnica Montana, Hypericum Perforatum, Symphytum Officinale, Bellis Perennis, Ledum Palustre, Sulphuricum Acidum, Calcarea Fluorica, Ferrum Phosphoricum, Rhus Tox, Ruta Graveolens, Natrum Sulphuricum

calendula officinalis, arnica montana, hypericum perforatum, symphytum officinale, bellis perennis, ledum palustre, sulphuricum acidum, calcarea fluorica, ferrum phosphoricum, rhus tox, ruta graveolens, natrum sulphuricum

INDICATIONS: For temporary relief of pain associated with bumps, bruises, abrasions, strains, sprains, fractures, stiffness; for all minor injuries.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Revefenacin

revefenacin

Anticholinergic [EPC]

11 DESCRIPTION YUPELRI is a sterile, clear, colorless, aqueous solution of revefenacin. Revefenacin, the active component of YUPELRI, is an anticholinergic. The chemical name for revefenacin is 1-(2-{4-[(4-carbamoylpiperidin-1-yl)methyl]- N -methylbenzamido}ethyl)piperidin-4-yl N -({1,1’-biphenyl}-2-yl)carbamate; its structural formula is: Revefenacin has a molecular weight of 597.76 and its empirical formula is C 35 H 43 N 5 O 4 .

Human Growth Hormone (2 Parts), Hypophysis Suis (2 Parts), Hepar Suis (1 Part)

human growth hormone (2 parts), hypophysis suis (2 parts), hepar suis (1 part)

Recombinant Human Growth Hormone [EPC]

INDICATIONS: Temporarily supports the body to rebalance Human Growth Hormone (HGH) output. Symptoms of imbalanced HGH may include: poor muscle/fat balance, dry wrinkled-skin, low energy, sleeplessness, weak immune system.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.